STXBP1, SYNGAP1, and WDR45, which are canonical epilepsy genes, were among the predicted targets, suggesting that tsRNAs may contribute to the broader molecular landscape underlying disease susceptibility (Zhang et al. 2024). The gene discussed is SYNGAP1; the disease is epilepsy.